prednisolone has been researched along with Mastocytosis, Systemic in 9 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Mastocytosis, Systemic: A group of disorders caused by the abnormal proliferation of MAST CELLS in a variety of extracutaneous tissues including bone marrow, liver, spleen, lymph nodes, and gastrointestinal tract. Systemic mastocytosis is commonly seen in adults. These diseases are categorized on the basis of clinical features, pathologic findings, and prognosis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Systemic mastocytosis is a rare myeloproliferative disease characterized by the uncontrolled proliferation of aberrant mast cells." | 1.43 | A unique presentation of pulmonary disease in advanced systemic mastocytosis, proven by the presence of mast cells in bronchoalveolar lavage: a case report. ( Broijl, A; Hermans, MA; van Daele, PL, 2016) |
| "Urolithiasis is expected to cause a considerable complication in patients with systemic mastocytosis." | 1.35 | Ureteral stones due to systemic mastocytosis: diagnostic and therapeutic characteristics. ( Homann, J; Kolck, UW; Molderings, GJ; Schröder, D; Solleder, G; von Kügelgen, I; Vorreuther, R, 2009) |
| "Systemic mastocytosis is a rare cause of vertebral fractures in young men." | 1.35 | Multimodal therapy for vertebral involvement of systemic mastocytosis. ( Brendel, C; Hamann, C; Hofbauer, LC; Krüger, A; Neubauer, A; Ramaswamy, A; Schnabel, M, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (77.78) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hermans, MA | 1 |
| Broijl, A | 1 |
| van Daele, PL | 1 |
| Molderings, GJ | 1 |
| Solleder, G | 1 |
| Kolck, UW | 1 |
| Homann, J | 1 |
| Schröder, D | 1 |
| von Kügelgen, I | 1 |
| Vorreuther, R | 1 |
| Krüger, A | 1 |
| Hamann, C | 1 |
| Brendel, C | 1 |
| Ramaswamy, A | 1 |
| Schnabel, M | 1 |
| Neubauer, A | 1 |
| Hofbauer, LC | 1 |
| Schipper, EM | 1 |
| Posthuma, W | 1 |
| Snieders, I | 1 |
| Brouwer, RE | 1 |
| Caksen, H | 1 |
| Odabas, D | 1 |
| Oner, AF | 1 |
| Cesur, Y | 1 |
| Arslan, S | 1 |
| Akbayram, S | 1 |
| Yuca, SA | 1 |
| Erol, M | 1 |
| Hauswirth, AW | 1 |
| Simonitsch-Klupp, I | 1 |
| Uffmann, M | 1 |
| Koller, E | 1 |
| Sperr, WR | 1 |
| Lechner, K | 1 |
| Valent, P | 1 |
| Sökler, M | 2 |
| Kanz, L | 2 |
| Mickys, U | 1 |
| Barakauskiene, A | 1 |
| De Wolf-Peeters, C | 1 |
| Geboes, K | 1 |
| De Hertogh, G | 1 |
1 review available for prednisolone and Mastocytosis, Systemic
| Article | Year |
|---|---|
Response to therapy with interferon alpha-2b and prednisolone in aggressive systemic mastocytosis: report of five cases and review of the literature.
Topics: Adult; Bone Marrow; Disease Progression; Drug Evaluation; Drug Therapy, Combination; Female; Fever; | 2004 |
8 other studies available for prednisolone and Mastocytosis, Systemic
| Article | Year |
|---|---|
A unique presentation of pulmonary disease in advanced systemic mastocytosis, proven by the presence of mast cells in bronchoalveolar lavage: a case report.
Topics: Adult; Anemia; Anti-Inflammatory Agents; Antineoplastic Agents; Bronchoalveolar Lavage; Cladribine; | 2016 |
Ureteral stones due to systemic mastocytosis: diagnostic and therapeutic characteristics.
Topics: Diagnosis, Differential; Glucocorticoids; Histamine H1 Antagonists, Non-Sedating; Histamine H2 Antag | 2009 |
Multimodal therapy for vertebral involvement of systemic mastocytosis.
Topics: Adult; Back Pain; Biomarkers; Biopsy; Bone Density; Bone Density Conservation Agents; Diphosphonates | 2009 |
Mastocytosis and diffuse large B-cell lymphoma, an unlikely combination.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclop | 2011 |
Use of interferon alpha-2b and prednisolone in the treatment of severe intractable diarrhea in a child with systemic mastocytosis.
Topics: Child; Diarrhea; Drug Therapy, Combination; Glucocorticoids; Humans; Interferon alpha-2; Interferon- | 2003 |
[Systemic mastocytosis].
Topics: Anti-Inflammatory Agents; Benzamides; Cladribine; Humans; Imatinib Mesylate; Immunosuppressive Agent | 2005 |
[Systemic mastocytosis].
Topics: Bone Marrow; Drug Therapy, Combination; Humans; Interferon-alpha; Mastocytosis, Systemic; Prednisolo | 2005 |
Aggressive systemic mastocytosis complicated by protein-losing enteropathy.
Topics: Anti-Inflammatory Agents; Colonoscopy; Female; Humans; Immunologic Factors; Interferon-alpha; Mastoc | 2007 |